ATE38470T1 - Pharmazeutisches produkt zur behandlung der hypertonie und thromboembolischer krankheiten. - Google Patents

Pharmazeutisches produkt zur behandlung der hypertonie und thromboembolischer krankheiten.

Info

Publication number
ATE38470T1
ATE38470T1 AT85101863T AT85101863T ATE38470T1 AT E38470 T1 ATE38470 T1 AT E38470T1 AT 85101863 T AT85101863 T AT 85101863T AT 85101863 T AT85101863 T AT 85101863T AT E38470 T1 ATE38470 T1 AT E38470T1
Authority
AT
Austria
Prior art keywords
hypertension
treatment
thromboembolic diseases
pharmaceutical product
pyridazinone
Prior art date
Application number
AT85101863T
Other languages
English (en)
Inventor
Juergen Dr Biedermann
Harald Dr Borbe
Erich Dr Graf
Gerd Dr Hilboll
Gerrit Dr Prop
Original Assignee
Nattermann A & Cie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nattermann A & Cie filed Critical Nattermann A & Cie
Application granted granted Critical
Publication of ATE38470T1 publication Critical patent/ATE38470T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT85101863T 1984-03-01 1985-02-21 Pharmazeutisches produkt zur behandlung der hypertonie und thromboembolischer krankheiten. ATE38470T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19843407509 DE3407509A1 (de) 1984-03-01 1984-03-01 Neue arzneimittelkombination zur behandlung von bluthochdruck und thromboembolischen erkrankungen
EP85101863A EP0156163B1 (de) 1984-03-01 1985-02-21 Pharmazeutisches Produkt zur Behandlung der Hypertonie und thromboembolischer Krankheiten

Publications (1)

Publication Number Publication Date
ATE38470T1 true ATE38470T1 (de) 1988-11-15

Family

ID=6229261

Family Applications (1)

Application Number Title Priority Date Filing Date
AT85101863T ATE38470T1 (de) 1984-03-01 1985-02-21 Pharmazeutisches produkt zur behandlung der hypertonie und thromboembolischer krankheiten.

Country Status (8)

Country Link
US (2) US4661487A (de)
EP (1) EP0156163B1 (de)
JP (1) JPS60202819A (de)
AT (1) ATE38470T1 (de)
DE (2) DE3407509A1 (de)
DK (1) DK93485A (de)
GR (1) GR850473B (de)
ZA (1) ZA851548B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3535170A1 (de) * 1985-10-02 1987-04-16 Basf Ag Verwendung von 2-aryl-3,4-diaza-bicyclo(4.n.0)alken-(2)-onen-(5) zur behandlung der herzinsuffizienz
DE3805635A1 (de) * 1988-02-24 1989-09-07 Thomae Gmbh Dr K Verwendung von benzimidazolen zur herstellung eines arzneimittels mit antiischaemischen wirkungen am herzen und dessen kombinationen mit ss-blockern oder bradycardica
DE68925799T2 (de) * 1988-12-21 1996-07-11 Texas Instruments Inc Einen metastabilen Zustand zulassende Kippschaltung
US20110015246A2 (en) * 2005-03-14 2011-01-20 Agean Llc Lofexidine enantiomers for use as a treatment for cns disease and pathologies and its chiral synthesis
US20090246256A1 (en) * 2008-03-27 2009-10-01 Al-Ghananeem Abeer M Compositions and Methods for Transmucosal Delivery of Lofexidine
WO2010075275A1 (en) * 2008-12-23 2010-07-01 Usworldmeds Llc Selective release of non-racemic mixtures of two enantiomers from tablets and capsules

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1795843U (de) 1959-06-12 1959-09-17 Johannes Schlueter Chem Fab Bohnergeraet mit vorratsbehaelter und einrichtung zur portionsweisen abgabe von fluessigwachs.
HU190412B (en) * 1981-09-17 1986-09-29 Warner-Lambert Co,Us Process for producing substituted 4,5-dihiydro-6-bracket-substituted-bracket closed-phenyl-3-bracket-2h-bracket closed-pyridazinones and 6-bracket-substituted-bracket closed-phenyl-3-bracket-2h-bracket closed-pyridazinones
DE3149009A1 (de) 1981-12-10 1983-06-23 A. Nattermann & Cie GmbH, 5000 Köln (-)-2-(1-(2,6-dichlorphenoxy)-ethyl)-1,3-diazacyclopent-2-en, dessen herstellung und seine verwendung in pharmazeutischen praeparaten
DE3212304A1 (de) * 1982-04-02 1983-10-06 Nattermann A & Cie Imidazolylphenyl-tetrahydropyridazine, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate
DE3241102A1 (de) * 1982-11-06 1984-05-10 A. Nattermann & Cie GmbH, 5000 Köln Imidazolylalkylthienyl-tetrahydropyridazine und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
US4746660A (en) 1988-05-24
DK93485D0 (da) 1985-02-28
JPS60202819A (ja) 1985-10-14
DE3407509A1 (de) 1985-09-05
DE3566079D1 (en) 1988-12-15
EP0156163A1 (de) 1985-10-02
GR850473B (de) 1985-05-31
EP0156163B1 (de) 1988-11-09
DK93485A (da) 1985-09-02
ZA851548B (en) 1985-10-30
US4661487A (en) 1987-04-28

Similar Documents

Publication Publication Date Title
IS1904B (is) Hliðstæðar aðferðir við framleiðslu á nýjum (R)-5-karbamóýl-8-flúor-3-N,N-tvíútskiptum-amínó-3,4-díhýdró-2H-1-bensópýrönum
HUP9600448A2 (hu) Naftilvegyületek, e vegyületeket tartalmazó gyógyszerkészítmények, eljárás előállításukra, intermedierjeik és alkalmazásuk
IL72120A0 (en) 2-pyrimidinyl-1-piperazine derivatives,their preparation and pharmaceutical compositions containing them
YU211087A (en) Process for obtaining new n-substituted benzimidazolic derivatives
DE3571982D1 (en) Benzisoselenazolethiones,process for their preparation and pharmaceutical products containing these compounds
ES486279A1 (es) Procedimiento para la obtencion de hidroxipropil-triazoles
MD382C2 (ro) Procedeu de obţinere a piperazinilalchil-3(2H)-piridazinonelor sau a sărurilor lor farmaceutice admisibile
HRP20010969B1 (en) Novel piperazinylalkylthiopyrimidine derivatives,
MX9403088A (es) Composiciones farmaceuticas que contienen deriva- dos de indol y metodos de uso.
FI91964C (fi) Menetelmä uusien, farmaseuttisesti aktiivisten 1-(hydroksistyryyli)-5H-2,3-bentsodiatsepiinijohdannaisten valmistamiseksi
ES8800161A1 (es) Procedimiento para la fabricacion de derivados quinolilglicinamidas
ATE38470T1 (de) Pharmazeutisches produkt zur behandlung der hypertonie und thromboembolischer krankheiten.
DE3361609D1 (en) New n-((2-oxo-1-pyrrolidinyl)acetyl)piperazines, the methods of producing such new compounds and their salts as well as pharmaceutical preparations for therapeutic use containing these compounds or salts
GR852395B (de)
NZ332545A (de)
ES8504810A1 (es) Procedimiento de preparar compuestos tiopiranopirimidinicos farmacologicamente activos.
HUP9800964A2 (hu) O- és S-tartalmú 6 tagú benzo-kondenzált heterociklusos vegyületek, eljárás ezek előállítására, és ezeket tartalmazó gyógyászati készítmények
ES8401947A1 (es) Procedimiento para la preparacion de (-)-2-1-(2,6-diclorofenoxi)-etil-1,3-diazaciclopent-2-eno.
ZA968762B (en) Derivatives of acid pyrazoles, their preparation process, their use as medicaments, their new use and the pharmaceutical compositions containing them.
ES8506717A1 (es) Procedimiento de preparacion de nuevos derivados de 1, 3-dihidro-6-metil-7-hidroxi-furo-(3, 4-c)-piridina
MX9704704A (es) Amidas de acido 4-amino-2-ureido-pirimidin-5-carboxilico, procedimientos para su obtencion, medicamentos que contienen estos compuestos, y su utilizacion.
WO1998056759A3 (de) Neue pentaerythritderivate, deren herstellung und verwendung sowie intermediate zur synthese derselben
FR2673105B1 (fr) Nouvelles compositions pharmaceutiques, notamment pour le traitement des colopathies fonctionnelles, et procedes de preparation de compositions et de medicaments, notamment pour le traitement de ces affections.
HUP9900916A2 (hu) Benzotiofénszármazékok felhasználása az érszövetek kalciumvezetékeit antagonizáló hatású gyógyszerkészítmények előállítására
NO160366C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive (2-((amino- eller nitro-pyridinyl)amino)-fenyl)arylmethanoner.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee